US Stock MarketDetailed Quotes
EVGN Evogene
- 0.5885
- +0.0584+11.02%
Close Jul 24 16:00 ET
- 0.7418
- +0.1533+26.05%
Post 19:49 ET
29.89MMarket Cap-1307P/E (TTM)
0.6299High0.5700Low765.91KVolume0.5900Open0.5301Pre Close452.68KTurnover1.64%Turnover RatioLossP/E (Static)50.79MShares1.100052wk High3.61P/B27.55MFloat Cap0.450252wk Low--Dividend TTM46.81MShs Float20.3890Historical High--Div YieldTTM11.30%Amplitude0.4502Historical Low0.5910Avg Price1Lot Size
Evogene Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 553.67%4.19M | 236.72%5.64M | -12.42%578K | 708.37%3.77M | 109.62%654K | 170.46%641K | 80.11%1.68M | 112.22%660K | 208.61%466K | 131.11%312K |
| Operating revenue | 553.67%4.19M | 236.72%5.64M | -12.42%578K | 708.37%3.77M | 109.62%654K | 170.46%641K | 80.11%1.68M | 112.22%660K | 208.61%466K | 131.11%312K |
| Cost of revenue | -3.73%310K | 86.14%1.69M | 9.34%398K | 325.83%511K | 75.95%461K | 97.55%322K | 18.51%909K | 36.33%364K | 18.81%120K | 104.69%262K |
| Gross profit | 1,116.30%3.88M | 415.40%3.95M | -39.19%180K | 841.04%3.26M | 286.00%193K | 331.08%319K | 369.94%766K | 572.73%296K | 592.00%346K | 614.29%50K |
| Operating expense | 11.96%7.97M | 9.92%30.46M | 91.47%7.81M | -0.05%7.44M | 0.46%8.09M | -12.47%7.12M | -10.96%27.71M | -53.32%4.08M | -13.51%7.44M | 8.10%8.06M |
| Selling and administrative expenses | 14.30%2.65M | -7.07%9.68M | -19.89%2.26M | -2.90%2.38M | 3.22%2.73M | -7.51%2.32M | 4.24%10.42M | -40.38%2.83M | 22.11%2.45M | 47.08%2.64M |
| -Selling and marketing expense | 24.00%992K | -0.49%1.01M | 10.40%-1.57M | -5.03%850K | -3.53%928K | -11.89%800K | 55.44%1.02M | ---1.75M | --895K | --962K |
| -General and administrative expense | 9.17%1.65M | -7.78%8.67M | -16.26%3.83M | -1.68%1.53M | 7.09%1.8M | -5.02%1.52M | 0.66%9.4M | 12.00%4.58M | -22.55%1.55M | -6.52%1.68M |
| Research and development costs | 0.02%4.8M | -0.07%20.78M | 16.66%5.55M | 1.34%5.06M | -0.89%5.37M | -14.68%4.8M | -1.58%20.79M | 18.88%4.75M | -24.33%5M | -4.26%5.42M |
| Other operating expenses | --519K | ---- | ---- | ---- | ---- | ---- | ---3.5M | ---- | ---- | ---- |
| Operating profit | 39.88%-4.09M | 1.61%-26.51M | -101.69%-7.63M | 41.06%-4.18M | 1.32%-7.9M | 15.63%-6.8M | 12.96%-26.94M | 56.49%-3.78M | 17.05%-7.1M | -7.53%-8.01M |
| Net non-operating interest income expense | 204.78%241K | 511.39%975K | -71.30%741K | 624.59%320K | 108.43%144K | 78.07%-230K | 12.22%-237K | 1,466.14%2.58M | -127.60%-61K | -410.16%-1.71M |
| Non-operating interest income | 32.14%407K | 585.71%1.25M | 124.14%120K | 121.13%429K | -11.94%391K | 651.22%308K | -37.46%182K | 29.60%-497K | -48.95%194K | -21.42%444K |
| Non-operating interest expense | -69.14%166K | -30.30%115K | 76.63%-779K | -57.25%109K | -88.53%247K | -50.64%538K | -47.62%165K | -336.83%-3.33M | 60.38%255K | 15,278.57%2.15M |
| Total other finance cost | ---- | -37.80%158K | ---- | ---- | ---- | ---- | 3.25%254K | ---- | ---- | ---- |
| Other net income (expense) | 82.38%-454K | -425.66%-2.58M | ||||||||
| Gain on sale of security | ---- | 82.38%-454K | ---- | ---- | ---- | ---- | -425.66%-2.58M | ---- | ---- | ---- |
| Income before tax | 45.27%-3.85M | 12.66%-25.99M | -94.41%-7.34M | 46.03%-3.86M | 20.16%-7.76M | 22.83%-7.03M | 2.23%-29.75M | 53.33%-3.78M | 14.12%-7.16M | -40.91%-9.72M |
| Income tax | 0 | -136.67%-33K | -108.89%-4K | -200.00%-5K | -44.74%21K | -2,350.00%-45K | 592.31%90K | 850.00%45K | -37.50%5K | 1,166.67%38K |
| Net income | 44.92%-3.85M | 13.03%-25.95M | -92.02%-7.34M | 46.14%-3.86M | 20.26%-7.78M | 23.34%-6.98M | 1.97%-29.84M | 52.73%-3.82M | 14.14%-7.16M | -41.40%-9.75M |
| Net income continuous Operations | 44.92%-3.85M | 13.03%-25.95M | -92.02%-7.34M | 46.14%-3.86M | 20.26%-7.78M | 23.34%-6.98M | 1.97%-29.84M | 52.73%-3.82M | 14.14%-7.16M | -41.40%-9.75M |
| Minority interest income | 102.54%18K | 35.28%-2.08M | 10.57%-736K | 120.36%126K | 19.08%-755K | 14.56%-710K | -20.89%-3.21M | -15.43%-823K | 15.55%-619K | -35.61%-933K |
| Net income attributable to the parent company | 38.40%-3.86M | 10.36%-23.88M | -120.18%-6.6M | 39.12%-3.98M | 20.38%-7.02M | 24.22%-6.27M | 4.16%-26.64M | 59.33%-3M | 14.01%-6.54M | -42.05%-8.82M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 38.40%-3.86M | 10.36%-23.88M | -120.18%-6.6M | 39.12%-3.98M | 20.38%-7.02M | 24.22%-6.27M | 4.16%-26.64M | 59.33%-3M | 14.01%-6.54M | -42.05%-8.82M |
| Basic earnings per share | 46.67%-0.08 | 20.00%-0.52 | -85.71%-0.13 | 50.00%-0.08 | 19.05%-0.17 | 25.00%-0.15 | 5.80%-0.65 | 61.11%-0.07 | 15.79%-0.16 | -40.00%-0.21 |
| Diluted earnings per share | 46.67%-0.08 | 20.00%-0.52 | -85.71%-0.13 | 50.00%-0.08 | 19.05%-0.17 | 25.00%-0.15 | 5.80%-0.65 | 61.11%-0.07 | 15.79%-0.16 | -40.00%-0.21 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg